Dawnrays Pharmaceutical (Holdings) logo

2348 - Dawnrays Pharmaceutical (Holdings) News Story

HK$1.06 -0.0  -0.9%

Last Trade - 2:36am

Sector
Healthcare
Size
Small Cap
Market Cap £158.3m
Enterprise Value £105.6m
Revenue £107.8m
Position in Universe 2246th / 5954

BRIEF-Dawnrays Pharmaceutical (Holdings) Says Unit Entered Into Phase II Construction Agreement

Fri 14th August, 2020 4:11pm
Aug 14 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
 2348.HK :
    * DAWNRAYS PHARMACEUTICAL (HOLDINGS)-  UNIT ENTERED INTO
PHASE II
CONSTRUCTION AGREEMENT WITH SUZHOU JIASHENG CONSTRUCTION
    * DAWNRAYS PHARMACEUTICAL (HOLDINGS)- UNIT APPOINTED SUZHOU
JIASHENG CONSTRUCTION AS CONTRACTOR TO CARRY OUT CONSTRUCTION
WORKS OF PRODUCTION PLANTS
    * DAWNRAYS PHARMACEUTICAL (HOLDINGS)- AGGREGATE CONTRACT
AMOUNT OF
RMB91.1 MILLION

Source text for Eikon:  ID:nHKS63jrWr 
Further company coverage:  2348.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.